Skip to main content
. 2019 Jun 6;37(21):1819–1827. doi: 10.1200/JCO.19.00014

FIG 2.

FIG 2.

Cumulative incidence of late relapse for (A) all histologies combined, (B) diffuse large B-cell lymphoma (DLBCL), and (C) indolent lymphoma in patients with DLBCL alone and in patients with concurrent DLBCL and indolent lymphoma. EFS24, event-free survival at 24 months.